chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vision is Very Blurry/eyesight got blurry; Hard to Read in Small Print; looked at her pupils, one was huge and one was small; felt like something was in her eye; at night time she can't see with the street lights and lights from the cars are blinding.  They only way she can see things is in the sunlight; Lost Part of Eye Sight; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 83 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Feb2021 13:00 (Lot number: EN6200) at the age of 83 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: Shingles vaccine, administration date: Jan2021, when the patient was 83 years old, for immunisation. The following information was reported: VISUAL IMPAIRMENT (non-serious) with onset 15Feb2021, outcome "not recovered", described as "Lost Part of Eye Sight"; VISION BLURRED (non-serious) with onset 27Feb2021, outcome "not recovered", described as "Vision is Very Blurry/eyesight got blurry"; VISUAL IMPAIRMENT (non-serious) with onset 27Feb2021, outcome "not recovered", described as "Hard to Read in Small Print"; MYDRIASIS (non-serious) with onset 27Feb2021, outcome "unknown", described as "looked at her pupils, one was huge and one was small"; OCULAR DISCOMFORT (non-serious) with onset 27Feb2021, outcome "unknown", described as "felt like something was in her eye"; NIGHT BLINDNESS (non-serious) with onset 27Feb2021, outcome "not recovered", described as "at night time she can't see with the street lights and lights from the cars are blinding.  They only way she can see things is in the sunlight". The events "vision is very blurry/eyesight got blurry", "hard to read in small print", "looked at her pupils, one was huge and one was small", "felt like something was in her eye" and "at night time she can't see with the street lights and lights from the cars are blinding.  they only way she can see things is in the sunlight" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: She mentioned that she has already seen her ophthalmologist and a retinal specialist, states they didn't give her any medicine and said it would resolve in 6-8 weeks but she doesn't know. She was really upset about it and she considers this very serious. She fears she might go blind and was weary of taking the 2nd dose. Additional vaccines administered on same date of the Pfizer Suspect was reported as none.  No follow-up attempts are possible. No further information is expected.
Approximately 6 hours after injection I began to feel as if my skin was burning and itching.  Had crawling sensation throughout body and throat felt a little tight/dry.  The burning, itching and crawling feeling continued for a couple weeks.  Had to take Allegra and Benadryl and currently am still taking it to ward of symptoms.
JANSSEN COVID-19 VACCINE EUA FEVER BEGAN 10 HOURS AFTER VACCINATION, TEMPERATURE 100.5 DEGREES.  HAD THE CHILLS FOR SEVERAL HOURS, VERY LITTLE SLEEP, FEVER BROKE BY 7AM NEXT DAY OR 22 HOURS AFTER VACCINATION.  AS DAY PROGRESSED WAS FEELING BETTER.  TOOK IBUPROFEN 19 HOURS AFTER VACCINATION, THEN EVERY SIX HOURS THEREAFTER.
TINNITUS; This spontaneous report received from a patient concerned a 68 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had excellent health and was an athlete. The patient previously received covid-19 vaccine ad26. cov2. s (dose number in series 1) (form of admin, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total, therapy start date was not reported for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (dose number in series 1).  The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1822811 expiry: unknown) dose was not reported, 1 total administered on 12-NOV-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in NOV-2021 (within 1 to 2 weeks after booster), the patient experienced tinnitus (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tinnitus. This report was non-serious.
Received dose from vials beyond 30-day use by date; Received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date) and PRODUCT STORAGE ERROR (Received dose from vials beyond 30-day use by date) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received dose from vials beyond 30-day use by date). On 18-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date) had resolved. At the time of the report, PRODUCT STORAGE ERROR (Received dose from vials beyond 30-day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the vial was refrigerated on 07-May-2021.  No concomitant medication was reported. No treatment information was reported.   This case was linked to MOD-2021-363032 (Patient Link).
Major headache, uncontrollable shaking, fever, upset stomach started around 4:30 AM and could not get out of bed for more than 12 hours. Started feeling better about 5:00 PM on 3/28/2019 (about 24 hours after vaccination). Arm was sore for about 3 days.
On July 7, 2021, my right thigh started itching in the evening, I was itching more in other parts of my body, and I could barely sleep because I awoke every 1.5 hours from scratching. I even noticed my left eye swelling. Thursday morning, I took Benadryl and used calamine lotion. That helped a little. I had used the max Benedryl so I reached out to my primary doctor's office and they called me and recommended I go to Urgent Care.  I went to Urgent Care that day and the doctor walked into the room and saw hives on my inner thigh. I did not see the hives before my time in the office.  The Doctor suggested a injection of allergy medicine for immediate relief as well as Allegra in the morning and Zyrtec in the evening. I took this dosing over the next few days until my follow-up visit.  At my follow-up visit I wasn't having any more issues so he said I could stop taking the Allegra and Zyrtec.  However, the itching continued when I when I stopped so I continued.  I notified my primary care doctor at my next visit and she referred me to a Allergy Specific.  From the time of my initial appointment about the itching till my primary care appointment my asthma started bothering me. I now take an inhaler daily and a Zyrtec daily.
I was not feeling right on 04/26/2022, I did 2 home tests one tested positive and one negative. On 04/25/2022 I did a PCR. The results came back on 04/26/2022 as positive.  My symptoms were a real bad headache and very tired and listless. Once my doctor put me  on Paxlovid I felt better the following day.  I feel great now and I tested myself on 05/05/2022 thru 05/7/2022 came back negative.
Dose Number: 1, 2, 3, COVID 19 Treatment; Dose Number: 1, 2, 3, COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 48-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2021 as dose 1, single (Lot number: EW0151), in left arm, on 28Apr2021 as dose 2, single (Lot number: EW0173), in left arm and on 20Nov2021 as dose 3 (booster), single (Lot number: EW0191) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Gout" (unspecified if ongoing); "Fish allergy: Allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "Dose Number: 1, 2, 3, COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: Body mass index: (unspecified date) 31.6; SARS-CoV-2 test: (unspecified date) Negative; (May2022) mild covid rebound. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Confusion, Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, chills, sore arm Narrative:  Fever 100.6, arthralgia, myalgia, nausea/vomiting, headache, confusion, chills, sore arm; taking APAP/ibuprofen.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Mar2021 as dose 1, single (Lot number: ER8732), in left arm and on 21Apr2021 as dose 2, single (Lot number: EW0775) at the age of 41 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 04Nov2021 as dose 3 (booster), single (Lot number: 039F21A) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa. Concomitant medication(s) included: MIRENA L; TOPIRAMATE. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient received treatment Paxlovid for the events. other medication in 2weeks product: IUD
My legs cramped and were so weak; My legs cramped and were so weak; I struggled to get of the toilet.; This spontaneous case was reported by a patient and describes the occurrence of MUSCULAR WEAKNESS (My legs cramped and were so weak), MUSCLE SPASMS (My legs cramped and were so weak) and MOBILITY DECREASED (I struggled to get of the toilet.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (My legs cramped and were so weak), MUSCLE SPASMS (My legs cramped and were so weak) and MOBILITY DECREASED (I struggled to get of the toilet.). At the time of the report, MUSCULAR WEAKNESS (My legs cramped and were so weak), MUSCLE SPASMS (My legs cramped and were so weak) and MOBILITY DECREASED (I struggled to get of the toilet.) outcome was unknown.            No concomitant medication was reported. . It was reported that second Covid vaccine and booster were what  would call severe. Fever, chills so severe, patient had 4 layers plus a winter coat and heating pad. Body pain lasted 48 hours. For the 4th booster, patient switched to Moderna and lost another two days with a worse reaction. Patient legs cramped and were so weak, he/she struggled to get of the toilet. Patient asked If there were no breathing problems, it's all dismissed. It was stated that patient knew another booster would come in the future. No treatment medication was reported.
pt recv vax 12AUG96 & 16AUG96 had large red arthus like rxn;
I believe I have been exposed to COVID although the test came out negative. I have also had bad body aches that I could barely move, worse then the ones I am normally used to. I have terrible congestion in my right ear. I reached out to my doctor who doesn't think I have COVID this time but believes I might have earlier in the month when I had a cold that I could barely breathe. I feel like I have been hit by a truck.
Severe injection site pain that began around 2 hours and went into the evening, severe in the evening and night. Light soreness continued over the next day. 3 hours after receiving the 2nd vaccine, nausea, loss of appetite and general 'unwell' feeling began. Nausea, fatigue, loss of appetite, headache continued the rest of the first day. Symptoms impacted ability to work, went home early from work.   Day 2: splitting headache, migraine, sinus pressure, joint pain which began in hips then spread to elbows, ankles, knees; muscle pain began in left calf then spread to shin. Injection site soreness was not severely painful any longer, mild pain. Loss of appetite continued. Nausea decreased, and no longer present by afternoon of day 2. Fatigue, increased sleep, sinus pressure in eyes, and cold chills persisted.  Day 3: Migraine was present still upon waking and continued for whole day; loss of appetite remained but improved by late afternoon on day 3. Joint and muscle pain continued for duration of day 3. Fatigue continued. Increased need for sleep most noticeable today. For the first time, ibuprofen was taken for symptoms after receiving the vaccine almost 50 hour prior.   Day 4: was able to return to work for the first time. Headache continued throughout day, nausea in the evening.   Day 5: Headache continued but went away.   Day 6 and Day 7, mild headache.
Patient began having tingling/burning pain along the jaw line (left side). Also started to get blisters/canker sores in the mouth. Resolved on its own in 2-3 days.
Patient had his first COVID vaccine 3/10/22. He had no history of seizures prior that, then had 3 seizures on 3/25/22. He was hospitalized on 3/25/22 at  Hospital for observation after first time seizures. He was released with PRN diastat and no daily medication. He received his second COVID vaccine 3/31/22 and had a seizure later that night.
PATIENT HAD PNEUMOVAX ON RIGHT DELTOID AREA ON 3/30/09 .ON 3/31/09 HE HAD MUSCLE ACHES AND ON 4/1/09 DEVELOPED FEVER , CHILLS AND NOTICED REDNESS IN DELTOID AREA, WHICH HAd INCREASED . HE HAS APPLIED ICE OVER AREA AND TAKEN IBUPROFEN AND TYLENOL FOR PAIN. Patient given CEPHALEXIN 500 MG PO QID X 10 DAYS and was told to follow-up if symptoms persisted. patient did not return in 10 days so symptoms improved.
Doses of Moderna Covid-19 bivalent were administered BUD to total of 17 recipients; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses of Moderna Covid-19 bivalent were administered BUD to total of 17 recipients) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses of Moderna Covid-19 bivalent were administered BUD to total of 17 recipients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses of Moderna Covid-19 bivalent were administered BUD to total of 17 recipients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Doses of Moderna Covid-19 bivalent were administered BUD to total of 17 recipients).    Concomitant medications were not reported.  This case is for 5th patient out of 17 patients reported. Treatment medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-713254 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-Feb-2023: Live Follow up received contains Patient details added. On 28-Feb-2023: Follow-up received contains no new information On 28-Feb-2023: Follow-up received contains no new information; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-713254:Patient 1 out 17 patients
Injection: local sore left arm Injection + 1 hr : arm sore subsided Injection + 9 hr :  body temperature rose to 99.8, light level of chill Injection + 10 hr: temperature rose to 100.4, light level of chill and fatigue over torso Injection + 21 hr: temperature came down to 99.5, light fatigue persisted, light level of right knee joint pain emerged Injection + 24 hr: temperature dropped to 99.1, fatigue and joint pain subsided Injection + 27 hr: temperature dropped to 98.8, no discomfort  Blood pressure and pulse normal throughout
With first  dose I had a headache that began day 4 after vaccine.  Headache was intense but would quickly go away with tylenol.  Headache wen away but I was left with the sensation of having "air pumped in my head".  Felt uncomfortable, and I was constantly aware of the sensation, made head feel somehow heavy.  I consulted my doctor, but no explanation.  Feeling went away 2 weeks after vaccination and never returned.  The second dose  (May 2, 2021) was much more concerning, as I began feeling different pain spots that would feel like stabbing at points. They all were on the left side of my body : lower back, inner arm, shoulder blade and my left breast.  The most concerning reaction had to do with swelling of my left breast, if was noticeably swollen and painful to the touch.  At time I felt the same stabbing pain I felt in other areas of my body.  The pain would come and go.  It took a month before all of this cleared and resolved. .  I saw my doctor and had a breast ultrasound, which came back normal.  I understand from reading some studies that moderna vaccine may have symptoms that mimic breast cancer, I wish this was listed somewhere as it was really scary to experience this type of pain and wondering if it was or not the vaccine.
Information has been received from a physician concerning a 4 year old male (chart # 1473) who on an unknown date was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (lot # 655747/1117F). Concomitant therapy was not reported. On an unknown date, the patient experienced skin raised 3" x 3" around the injection site. The patient received measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) in the right thigh. Additional information has been requested.
COVID infection diagnosed; COVID infection diagnosed; fatigue; low grade temp; muscle aches; nasal congestion; sneezing; dry cough; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single and dose 2 of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on Feb2021 as dose 2, single for covid-19 immunisation. There is no relevant medical history, No underlying immune conditions or medications. There were no concomitant medications. The patient experienced covid infection diagnosed on 29Aug2021, fatigue, low grade temp, muscle aches, nasal congestion, sneezing, and dry cough on an unspecified date in Aug2021. The patient underwent lab tests and procedures which included body temperature low grade temp on 29Aug2021, sars-cov-2 test breakthrough covid infection. Breakthrough COVID infection diagnosed on 29Aug quick test on 29Aug2021. The outcome of the events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
DIZZINESS, NAUSEA, SWEATING, SLEEPING SENSATION IN A CORNER OF THE TONGUE, BP A LITTLE HIGH AT THE BEGINNING AND THEN LOW. OXYGEN WAS ADMINISTERED AND WAS TAKEN TO THE HOPITAL IN AMBULANCE
Pt was given MMR and DTAP on 03/25/05 at 10:30AM. Mom called and reported rash/hives behind ears, trunk and arms. At 6:15PM on 03/25/05 went to ER for evaluation. Was given Prednisone and Benadryl. Rechecked in clinic on 03/29/05. No rash noted.
Chills and shivering Jun 10, 1:00 and 14:00  Headache Jun 10, 9:00
NO ADVERSE EVENTS HOWEVER DIAGNOSED WITH COVID-19 PNEUMONIA 10/10/2021
Mother called clinic 031208 reported child developed a rash on 031008, continued 031108, resolving 031208.  She stated "rash on forehead, both face cheeks, chest, stomach.  No elevations or discoloration, complained of itchy feeling.  No other complaints."  Child saw PSP, he did not feel rash was due to vaccines.  Reported above to doctors.
10-15 minutes after the injection was given patient stating that she was having tongue swelling on the right side towards the back. Patient also stating that she was having some tingling on right side of face. Patient denied trouble breathing or increased thirst.  Vitals were taken- BP: 136/88, Pulse: 79, O2Sat: 97%. Patient was seen by provider, advised to receive 50mg of oral Benadryl given to patient @ 10:50am. Pt was feeling better, but did have tongue swelling.
Redness, swelling (painful), area hot to touch, had chills/shakes for about 45 minutes then those passed, all of this occurred about at elbow under injection site not around or near.
Patient felt chills at 9pm, 10 hours after vaccine administration.   Temperature  reached 103 half an hour later at which point naproxen was taken.  By 10pm, temperature had reached 106 degrees and patient went to ED.  Initial temperature taken orally at 102.8, however patient was mouth breathing.  Patient given acetaminophen 650mg at 11:00pm.  1L NS bolus administered.  Temperature at 11:30pm was taken orally again at 103.1, though patient was still mouth breathing. Retaken temporally at 40.5C.  Nurse applied ice packs  to groin, arm pits and back of neck. Patient able to return home after several hours when temp dropped back to 103.    Patient experienced chest pain, chest xray and troponins negative.  Only abnormal lab finding was a low potassium at 3.1.
Within a few hours, I experienced shortness of breath, chest tightness, difficulty breathing, dry cough, and ear/throat swelling. Around 5 pm, my eyes became swollen, along with my face. I took benadryl and tylenol  at 4pm and 8 pm to relieve some of the symptoms. I rested and used a cool, damp cloth on my eyes to help with swelling.
This spontaneous report as received from a heath care worker and refers to a 28 year old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. It was reported that on an unspecified date, an unspecified 28 year old patient was vaccinated with GARDASIL 9, (dosage, route, lot number and expiration not reported) for prophylaxis. No adverse event was reported. No additional information was received. Additional information has been requested.